Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.568
-0.018 (-2.99%)
At close: Oct 25, 2024, 4:00 PM
0.584
+0.017 (2.98%)
After-hours: Oct 25, 2024, 6:22 PM EDT

Spruce Biosciences Revenue

Spruce Biosciences had revenue of $1.61M in the quarter ending June 30, 2024, a decrease of -25.64%. This brings the company's revenue in the last twelve months to $9.57M, up 131.82% year-over-year. In the year 2023, Spruce Biosciences had annual revenue of $10.09M.

Revenue (ttm)
$9.57M
Revenue Growth
+131.82%
P/S Ratio
2.50
Revenue / Employee
$330,069
Employees
29
Market Cap
23.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.09M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Retractable Technologies 38.25M
Ekso Bionics Holdings 18.16M
BioXcel Therapeutics 2.40M
Aprea Therapeutics 1.28M
OneMedNet 1.02M
Revenue Rankings